Development of a novel peripherally acting alpha2A-adrenergic receptor antagonist for anti-diabetic
Feng Hong, Jingyi Wang, Dongsheng Chen, Qian Wang, Shiyi Gan, Fang Ye, Lihua Chen, Huixia Ren, Tongran Zhang, Yinfang Xie, Xiaoyuan Jing, Ruoxi Wang, Zhibin Xu, Jiayan Ren, Cuihan Shi, , Zuxin Chen
This paper develops a novel peripherally acting alpha2A-adrenergic receptor antagonist, CDS479-2, which improves glucose control in diabetic mice without central side effects.
bioRxiv · Dec 17, 2024 · PreprintPharmacology & Toxicology